GSK plc
CIK
1131399
Location
London, X0
Portfolio Value
Small
$599,153,374
Diversification
Moderately concentrated
Filing Date
Global Rank
#2,361
/ 8,603
▼ 301
· as of Mar 2026
Top Industry
Biotechnology
98.4%
3Y Alpha vs SPY
-64.2%
Period ended 3 months ago
Filed May 14, 2026 · 56d
2 quarters · since Dec 2025
Clone Performance
Feb 2026–Jul 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
-16.0%
SPY
+9.6%
Annualised alpha
-61.7%
Max drawdown
−37.3%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
13 positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Top Position
25.6%
−13.2 pts
Top 5
81.1%
−1.8 pts
Top 10
97.3%
−0.6 pts
HHI
1,597
Moderately concentrated−602
Portfolio Trend
2 quarters · across all stocks
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $599,153,374 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increasedNo qualifying positions this quarter.
Trimmed
Positions the filer reducedNo qualifying positions this quarter.
New Positions
Positions the filer opened this quarterNo qualifying positions this quarter.
Sold Out
Positions the filer fully exited
1 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| SENS | Senseonics Holdings, Inc. | 10,856 | $59,925 | |
| No positions match the current search. | ||||
13 positions ·
$599,153,374 total
· as of Mar 31, 2026
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| CRSP |
CRISPR Therapeutics AG
Healthcare
|
Held | 3,220,627 | $153,205,226 | 25.57% | |
| WVE |
Wave Life Sciences Ltd.
Healthcare
|
Held | 18,245,691 | $132,281,259 | 22.08% | |
| BNTX |
BioNTech SE
Healthcare
|
Held | 889,824 | $79,087,557 | 13.20% | |
| VIR |
Vir Biotechnology, Inc.
Healthcare
|
Held | 8,550,954 | $76,616,547 | 12.79% | |
| IDYA |
IDEAYA Biosciences, Inc.
Healthcare
|
Held | 1,333,333 | $44,426,655 | 7.41% | |
| LYEL |
Lyell Immunopharma, Inc.
Healthcare
|
Held | 1,512,659 | $30,343,939 | 5.06% | |
| CYTK |
Cytokinetics Inc
Healthcare
|
Held | 340,434 | $22,438,004 | 3.74% | |
| SPRO |
Spero Therapeutics, Inc.
Healthcare
|
Held | 9,190,606 | $21,506,018 | 3.59% | |
| FULC |
Fulcrum Therapeutics, Inc.
Healthcare
|
Held | 1,785,714 | $13,696,426 | 2.29% | |
| CVRX |
CVRx, Inc.
Healthcare
|
Held | 1,007,583 | $9,531,735 | 1.59% | |
| BCYC |
Bicycle Therapeutics PLC
Healthcare
|
Held | 1,529,561 | $7,097,163 | 1.18% | |
| NKTX |
Nkarta, Inc.
Healthcare
|
Held | 3,150,732 | $6,648,044 | 1.11% | |
| RGNX |
REGENXBIO Inc.
Healthcare
|
Held | 271,456 | $2,274,801 | 0.38% |